🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to evaluate the immunogenicity of na...
Status
Terminated
Location
Research Site
Start Date
2014-12-01
Trial ID
NCT02142192
Treatments Being Tested
The purpose of this study is to evaluate the impact of an early treatment w...
Status
Completed
Location
Research Site
Start Date
2013-11-12
Trial ID
NCT04832399
Treatments Being Tested
The primary objective is to evaluate the safety and tolerability of nataliz...
Status
Completed
Location
Research Site
Start Date
2012-05
Trial ID
NCT02142205
Treatments Being Tested
The primary objective is to assess the pharmacokinetic (PK) profile of nata...
Status
Completed
Location
Research Site
Start Date
2008-11
Trial ID
NCT00744679
Treatments Being Tested
The primary objectives of the study are to estimate the risk of major conge...
Status
Recruiting
Location
University of Colorado Anschutz Medical Campus
Start Date
2023-10-27
Trial ID
NCT05658497
Treatments Being Tested
The primary objective of the study is to retrospectively investigate the pr...
Status
Completed
Location
Research Site 1
Start Date
2015-12-31
Trial ID
NCT02677077
Treatments Being Tested
The primary objective of the study is to determine whether one 300 mg dose ...
Status
Completed
Location
Research Site
Start Date
2014-01
Trial ID
NCT01955707
Treatments Being Tested
The primary objectives for the initial treatment period of this study are t...
Status
Terminated
Location
Research Site
Start Date
2006-03
Trial ID
NCT00297232
Treatments Being Tested
The primary objective of the study is to further evaluate the long-term saf...
Status
Completed
Location
Research Site
Start Date
2010-10
Trial ID
NCT01416155
Treatments Being Tested
The primary objective of this study is to assess the effect of natalizumab ...
Status
Terminated
Location
Research Site
Start Date
2014-11-30
Trial ID
NCT02342704
Treatments Being Tested